Brief: Oxford Biomedica Reiterates FY25 Rev Guidance

Oxford BioMedica

28/07/2025 07:29

July 28 (Reuters) - Oxford BioMedica PLC OXB.L:

OXFORD BIOMEDICA PLC  - HALF YEAR TRADING UPDATE

OXFORD BIOMEDICA PLC - REITERATES FY 25  £160-170 MILLION REVENUE GUIDANCE

OXFORD BIOMEDICA PLC - REPORTS H1 2025 REVENUES UP 38%-44%

OXFORD BIOMEDICA : STRONG ORDER BOOK REINFORCING CONFIDENCE IN BOTH FY 2025 & MEDIUM-TERM REVENUE GROWTH

Source text: ID:nRSb6974Sa

Further company coverage: OXB.L

 ((Reuters.Briefs@thomsonreuters.com))